Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: novel acyltriazene antitumor agents

Sep. 8, 1999

Cyclic peptide represents new lead for tumor-targeting anticancer therapies

Sep. 7, 1999

Schering-Plough and British Biotech to develop MMPIs for treatment of cancer

Sep. 7, 1999

UroGenesys announces U.S. patent for PSA promoter sequences

Sep. 7, 1999

New protein farnesyltransferase inhibitors in the AstraZeneca pipeline

Sep. 6, 1999

3-D discloses inhibitors of trypsin-like serine proteases

Sep. 6, 1999

Promising results achieved in phase II study of thalidomide in multiple myeloma

Sep. 6, 1999

Synthesis and mechanism of action of a natural compound acting on a previously undefined target

Sep. 3, 1999

Potent protein farnesyltransferase inhibitors emerge from Parke-Davis program

Sep. 3, 1999

Licensing opportunity from NIH: geldanamycins as inhibitors of the HGF/SF-Met pathway

Sep. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...